pancreatic cancer

You have access
Aberrant Methylation of Tumor Suppressive miRNAs in Bile from Patients With Pancreaticobiliary Diseases
KOUSHIRO OHTSUBO, KUNIO MIYAKE, SACHIKO ARAI, KOJI FUKUDA, NAOHIRO YANAGIMURA, CHIAKI SUZUKI, SAKIKO OTANI, YUTA ADACHI, AZUSA TANIMOTO, AKIHIRO NISHIYAMA, KANAME YAMASHITA, SHINJI TAKEUCHI, KENJI NOTOHARA, KENICHI YOSHIMURA and SEIJI YANO

Anticancer Research October 2019, 39 (10) 5449-5459; DOI: https://doi.org/10.21873/anticanres.13738
You have access
Brexpiprazole Reduces Survivin and Reverses EGFR Tyrosine Kinase Inhibitor Resistance in Lung and Pancreatic Cancer
TOMOMI SANOMACHI, SHUHEI SUZUKI, KEITA TOGASHI, SHIZUKA SEINO, TAKASHI YOSHIOKA, CHIFUMI KITANAKA, MASASHI OKADA and MASAHIRO YAMAMOTO

Anticancer Research September 2019, 39 (9) 4817-4828; DOI: https://doi.org/10.21873/anticanres.13667
You have access
Color-coded Imaging of the Fate of Cancer-cell-derived Exosomes During Pancreatic Cancer Metastases in a Nude-mouse Model
TOMOYUKI SATAKE, ATSUSHI SUETSUGU, MIKI NAKAMURA, TAKAHIRO KUNISADA, SHIGETOYO SAJI, HISATAKA MORIWAKI, MASAHITO SHIMIZU and ROBERT M. HOFFMAN

Anticancer Research August 2019, 39 (8) 4055-4060; DOI: https://doi.org/10.21873/anticanres.13561
You have access
Potential Pitfalls of Diaphragm Structural Matching in Carbon-ion Radiotherapy for Pancreatic Cancer
YUSUKE ITABASHI, YOSHIKI KUBOTA, MASAHIKO OKAMOTO, KAZUHISA TSUDA, SHINTARO SHIBA, YOSHIHIKO HOSHINO, TAKAYUKI SUTO, TATSUYA OHNO and TAKASHI NAKANO

Anticancer Research August 2019, 39 (8) 4351-4356; DOI: https://doi.org/10.21873/anticanres.13603
You have access
The Role of PEDF in Pancreatic Cancer
DANIEL ANSARI, CARL ALTHINI, HENRIK OHLSSON, MONIKA BAUDEN and ROLAND ANDERSSON

Anticancer Research July 2019, 39 (7) 3311-3315; DOI: https://doi.org/10.21873/anticanres.13473
You have access
The Hippo Signaling Pathway in Pancreatic Cancer
DANIEL ANSARI, HENRIK OHLSSON, CARL ALTHINI, MONIKA BAUDEN, QIMIN ZHOU, DINGYUAN HU and ROLAND ANDERSSON

Anticancer Research July 2019, 39 (7) 3317-3321; DOI: https://doi.org/10.21873/anticanres.13474
You have access
State of the Art for Metastatic Pancreatic Cancer Treatment: Where Are We Now?
RITA BALSANO, CHIARA TOMMASI and INGRID GARAJOVA

Anticancer Research July 2019, 39 (7) 3405-3412; DOI: https://doi.org/10.21873/anticanres.13484
You have access
IL-29 Exhibits Anti-Tumor Effect on Pan-48 Pancreatic Cancer Cells by Up-regulation of P21 and Bax
DEAN BALABANOV, LEI ZHAO, ZIWEN ZHU, ZACHARY E. HUNZEKER, HANNAH M. TONNER, VIVI A. DING, MARK R. WAKEFIELD, QIAN BAI and YUJIANG FANG

Anticancer Research July 2019, 39 (7) 3493-3498; DOI: https://doi.org/10.21873/anticanres.13495
You have access
Uridine Cytidine Kinase 2 as a Potential Biomarker for Treatment with RX-3117 in Pancreatic Cancer
BTISSAME EL HASSOUNI, JESSICA INFANTE, GIULIA MANTINI, CLAUDIO RICCI, NICCOLA FUNEL, ELISA GIOVANNETTI and GODEFRIDUS J. PETERS

Anticancer Research July 2019, 39 (7) 3609-3614; DOI: https://doi.org/10.21873/anticanres.13508
You have access
Biological Evaluation of the Antiproliferative and Anti-migratory Activity of a Series of 3-(6-Phenylimidazo[2,1-b][1,3,4]thiadiazol-2-yl)-1H-indole Derivatives Against Pancreatic Cancer Cells
GIOVANNA LI PETRI, STELLA CASCIOFERRO, BTISSAME EL HASSOUNI, DANIELA CARBONE, BARBARA PARRINO, GIROLAMO CIRRINCIONE, GODEFRIDUS J. PETERS, PATRIZIA DIANA and ELISA GIOVANNETTI

Anticancer Research July 2019, 39 (7) 3615-3620; DOI: https://doi.org/10.21873/anticanres.13509

Main menu

User menu

Search

pancreatic cancer

Pages